Silk Road Medical (SILK) Stock Forecast, Price Target & Predictions
SILK Stock Forecast
Silk Road Medical stock forecast is as follows: an average price target of $30.58 (represents a 11.24% upside from SILK’s last price of $27.49) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.
SILK Price Target
SILK Analyst Ratings
Silk Road Medical Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jun 18, 2024 | Frank Takkinen | Lake Street | $27.50 | $26.80 | 2.59% | 0.04% |
Jun 14, 2024 | David Toung | Argus Research | $32.00 | $21.19 | 51.01% | 16.41% |
May 01, 2024 | Adam Maeder | Piper Sandler | $20.00 | $18.26 | 9.53% | -27.25% |
Apr 03, 2024 | Frank Takkinen | Loop Capital Markets | $28.00 | $17.43 | 60.64% | 1.86% |
Mar 07, 2024 | Steve Silver | Argus Research | $24.00 | $15.98 | 50.19% | -12.70% |
Sep 06, 2023 | Suraj Kalia | Oppenheimer | $30.00 | $19.14 | 56.74% | 9.13% |
Jul 18, 2022 | - | Stifel Nicolaus | $46.00 | $39.36 | 16.86% | 67.33% |
Apr 06, 2022 | Adam Maeder | Piper Sandler | $43.00 | $42.97 | 0.07% | 56.42% |
Silk Road Medical Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 5 |
Avg Price Target | - | - | $26.30 |
Last Closing Price | $27.49 | $27.49 | $27.49 |
Upside/Downside | -100.00% | -100.00% | -4.33% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jun 18, 2024 | Lake Street | Buy | Hold | Downgrade |
May 01, 2024 | Piper Sandler | Neutral | Neutral | Hold |
Apr 29, 2024 | Lake Street | Buy | Buy | Hold |
Apr 03, 2024 | Lake Street | Buy | Buy | Hold |
Jan 19, 2024 | Raymond James | - | Buy | Upgrade |
Sep 06, 2023 | Oppenheimer | - | Outperform | Initialise |
Jul 12, 2023 | J.P. Morgan | - | Neutral | Downgrade |
May 22, 2023 | Argus Research | Buy | Buy | Hold |
May 15, 2023 | Wolfe Research | - | Underperform | Downgrade |
Apr 03, 2023 | Citigroup | Neutral | Buy | Upgrade |
Silk Road Medical Financial Forecast
Silk Road Medical Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | $44.44M | $45.30M | $40.13M | $40.07M | $37.37M | $33.17M | $28.02M | $28.27M | $24.70M | $26.46M | $22.05M | $21.13M | $20.07M | $15.09M | $18.93M | $18.63M | $17.03M | $14.93M | $12.77M |
Avg Forecast | $58.94M | $55.20M | $55.16M | $52.45M | $50.91M | $48.75M | $49.74M | $44.67M | $41.93M | $44.53M | $43.24M | $40.69M | $37.35M | $33.40M | $31.04M | $27.10M | $25.91M | $24.32M | $25.34M | $21.29M | $21.35M | $19.59M | $9.47M | $17.33M | $17.97M | $15.90M | $13.64M | $12.19M |
High Forecast | $58.94M | $55.20M | $55.16M | $52.45M | $50.91M | $49.62M | $49.74M | $44.67M | $42.34M | $44.69M | $43.24M | $40.69M | $37.35M | $33.40M | $31.04M | $27.10M | $25.91M | $24.32M | $25.34M | $21.29M | $21.35M | $19.59M | $9.47M | $17.33M | $17.97M | $15.90M | $13.64M | $12.19M |
Low Forecast | $58.94M | $55.20M | $55.16M | $52.45M | $50.91M | $47.60M | $49.74M | $44.67M | $41.70M | $44.36M | $43.24M | $40.69M | $37.35M | $33.40M | $31.04M | $27.10M | $25.91M | $24.32M | $25.34M | $21.29M | $21.35M | $19.59M | $9.47M | $17.33M | $17.97M | $15.90M | $13.64M | $12.19M |
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | 1.00% | 1.05% | 0.99% | 1.07% | 1.12% | 1.07% | 1.03% | 1.09% | 1.02% | 1.04% | 1.04% | 0.99% | 1.02% | 1.59% | 1.09% | 1.04% | 1.07% | 1.09% | 1.05% |
Silk Road Medical EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | $-13.67M | $-11.77M | $-13.79M | $-10.88M | $-8.61M | $-14.12M | $-16.06M | $-13.49M | $-12.76M | $-9.45M | $-9.67M | $-15.59M | $-8.75M | $-8.82M | $-8.41M | $-6.75M | $-6.51M | $-10.44M | $-22.47M |
Avg Forecast | $-24.87M | $-23.29M | $-23.27M | $-22.13M | $-21.48M | $-20.57M | $-20.98M | $-15.59M | $-17.69M | $-18.79M | $-18.24M | $-14.17M | $-12.37M | $-14.09M | $-13.09M | $-12.88M | $-10.93M | $-10.26M | $-10.69M | $-11.66M | $-9.01M | $-8.27M | $-3.99M | $-8.14M | $-7.58M | $-6.71M | $-5.75M | $-1.23B |
High Forecast | $-24.87M | $-23.29M | $-23.27M | $-22.13M | $-21.48M | $-20.08M | $-20.98M | $-12.47M | $-17.59M | $-18.72M | $-18.24M | $-11.34M | $-9.89M | $-14.09M | $-13.09M | $-10.31M | $-10.93M | $-10.26M | $-10.69M | $-9.33M | $-9.01M | $-8.27M | $-3.99M | $-6.51M | $-7.58M | $-6.71M | $-5.75M | $-984.86M |
Low Forecast | $-24.87M | $-23.29M | $-23.27M | $-22.13M | $-21.48M | $-20.93M | $-20.98M | $-18.70M | $-17.86M | $-18.86M | $-18.24M | $-17.00M | $-14.84M | $-14.09M | $-13.09M | $-15.46M | $-10.93M | $-10.26M | $-10.69M | $-13.99M | $-9.01M | $-8.27M | $-3.99M | $-9.77M | $-7.58M | $-6.71M | $-5.75M | $-1.48B |
Surprise % | - | - | - | - | - | - | - | - | - | 0.73% | 0.65% | 0.97% | 0.88% | 0.61% | 1.08% | 1.25% | 1.23% | 1.24% | 0.88% | 0.83% | 1.73% | 1.06% | 2.21% | 1.03% | 0.89% | 0.97% | 1.81% | 0.02% |
Silk Road Medical Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | $-12.79M | $-13.48M | $-16.01M | $-12.60M | $-11.41M | $-14.64M | $-17.40M | $-15.33M | $-13.88M | $-10.54M | $-10.69M | $-16.76M | $-10.31M | $-10.35M | $-9.94M | $-8.29M | $-8.01M | $-11.96M | $-24.16M |
Avg Forecast | $-11.59M | $-12.48M | $-12.92M | $-15.21M | $-13.98M | $-15.11M | $-14.81M | $-16.74M | $-16.67M | $-13.97M | $-15.42M | $-15.21M | $-13.47M | $-17.90M | $-17.78M | $-13.83M | $-14.15M | $-12.89M | $-14.47M | $-12.89M | $-11.07M | $-11.30M | $-14.60M | $-9.62M | $-10.57M | $-10.70M | $-10.77M | $-1.32B |
High Forecast | $-11.59M | $-12.48M | $-12.92M | $-15.21M | $-13.98M | $-13.43M | $-14.81M | $-13.39M | $-12.92M | $-13.97M | $-15.42M | $-12.17M | $-10.77M | $-17.90M | $-17.78M | $-11.07M | $-14.15M | $-12.89M | $-14.47M | $-10.31M | $-11.07M | $-11.30M | $-14.60M | $-7.70M | $-10.57M | $-10.70M | $-10.77M | $-1.06B |
Low Forecast | $-11.59M | $-12.48M | $-12.92M | $-15.21M | $-13.98M | $-16.79M | $-14.81M | $-20.08M | $-23.33M | $-13.97M | $-15.42M | $-18.26M | $-16.16M | $-17.90M | $-17.78M | $-16.60M | $-14.15M | $-12.89M | $-14.47M | $-15.47M | $-11.07M | $-11.30M | $-14.60M | $-11.54M | $-10.57M | $-10.70M | $-10.77M | $-1.59B |
Surprise % | - | - | - | - | - | - | - | - | - | 0.92% | 0.87% | 1.05% | 0.94% | 0.64% | 0.82% | 1.26% | 1.08% | 1.08% | 0.73% | 0.83% | 1.51% | 0.91% | 0.71% | 1.03% | 0.78% | 0.75% | 1.11% | 0.02% |
Silk Road Medical SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | $36.01M | $35.83M | $34.08M | $32.52M | $28.82M | $27.70M | $27.27M | $27.59M | $25.05M | $22.55M | $21.19M | $20.87M | $19.20M | $15.76M | $19.69M | $18.16M | $17.06M | $14.13M | $13.87M |
Avg Forecast | $54.34M | $50.88M | $50.85M | $48.35M | $46.93M | $44.94M | $45.86M | $27.37M | $38.66M | $41.05M | $39.86M | $24.88M | $25.30M | $30.79M | $28.61M | $22.62M | $23.88M | $22.42M | $23.36M | $19.63M | $19.68M | $18.06M | $8.73M | $15.97M | $16.57M | $14.66M | $12.57M | $11.24M |
High Forecast | $54.34M | $50.88M | $50.85M | $48.35M | $46.93M | $45.75M | $45.86M | $32.84M | $39.03M | $41.20M | $39.86M | $29.86M | $30.35M | $30.79M | $28.61M | $27.14M | $23.88M | $22.42M | $23.36M | $19.63M | $19.68M | $18.06M | $8.73M | $15.97M | $16.57M | $14.66M | $12.57M | $11.24M |
Low Forecast | $54.34M | $50.88M | $50.85M | $48.35M | $46.93M | $43.89M | $45.86M | $21.89M | $38.45M | $40.90M | $39.86M | $19.90M | $20.24M | $30.79M | $28.61M | $18.09M | $23.88M | $22.42M | $23.36M | $19.63M | $19.68M | $18.06M | $8.73M | $15.97M | $16.57M | $14.66M | $12.57M | $11.24M |
Surprise % | - | - | - | - | - | - | - | - | - | 0.88% | 0.90% | 1.37% | 1.29% | 0.94% | 0.97% | 1.21% | 1.16% | 1.12% | 0.97% | 1.08% | 1.06% | 1.06% | 1.81% | 1.23% | 1.10% | 1.16% | 1.12% | 1.23% |
Silk Road Medical EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 4 | 7 | 5 | 6 | 3 | 2 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 4 |
EPS | - | - | - | - | - | - | - | - | - | $-0.33 | $-0.35 | $-0.42 | $-0.33 | $-0.32 | $-0.42 | $-0.50 | $-0.44 | $-0.40 | $-0.31 | $-0.31 | $-0.49 | $-0.31 | $-0.32 | $-0.32 | $-0.27 | $-0.26 | $-0.42 | $-0.84 |
Avg Forecast | $-0.29 | $-0.32 | $-0.33 | $-0.38 | $-0.35 | $-0.38 | $-0.37 | $-0.40 | $-0.42 | $-0.35 | $-0.39 | $-0.40 | $-0.38 | $-0.45 | $-0.45 | $-0.37 | $-0.36 | $-0.33 | $-0.37 | $-0.39 | $-0.28 | $-0.29 | $-0.37 | $-0.31 | $-0.27 | $-0.27 | $-0.27 | $-0.32 |
High Forecast | $-0.29 | $-0.32 | $-0.33 | $-0.38 | $-0.35 | $-0.34 | $-0.37 | $-0.40 | $-0.33 | $-0.35 | $-0.39 | $-0.40 | $-0.38 | $-0.45 | $-0.45 | $-0.37 | $-0.36 | $-0.33 | $-0.37 | $-0.39 | $-0.28 | $-0.29 | $-0.37 | $-0.31 | $-0.27 | $-0.27 | $-0.27 | $-0.32 |
Low Forecast | $-0.29 | $-0.32 | $-0.33 | $-0.38 | $-0.35 | $-0.42 | $-0.37 | $-0.40 | $-0.59 | $-0.35 | $-0.39 | $-0.40 | $-0.38 | $-0.45 | $-0.45 | $-0.37 | $-0.36 | $-0.33 | $-0.37 | $-0.39 | $-0.28 | $-0.29 | $-0.37 | $-0.31 | $-0.27 | $-0.27 | $-0.27 | $-0.32 |
Surprise % | - | - | - | - | - | - | - | - | - | 0.94% | 0.90% | 1.05% | 0.88% | 0.71% | 0.94% | 1.35% | 1.23% | 1.23% | 0.85% | 0.79% | 1.75% | 1.09% | 0.87% | 1.04% | 1.01% | 0.96% | 1.54% | 2.66% |
Silk Road Medical Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
SGHT | Sight Sciences | $4.66 | $10.25 | 119.96% | Hold |
NPCE | NeuroPace | $6.37 | $12.88 | 102.20% | Buy |
FNA | Paragon 28 | $6.06 | $11.50 | 89.77% | Buy |
OFIX | Orthofix Medical | $17.33 | $31.00 | 78.88% | - |
LUNG | Pulmonx | $7.12 | $11.93 | 67.56% | Buy |
TMDX | TransMedics Group | $84.97 | $126.75 | 49.17% | Buy |
SIBN | SI-BONE | $13.63 | $20.00 | 46.74% | Buy |
LIVN | LivaNova | $49.01 | $70.50 | 43.85% | Buy |
KIDS | OrthoPediatrics | $28.74 | $39.60 | 37.79% | Buy |
RXST | RxSight | $51.25 | $70.11 | 36.80% | Buy |
NARI | Inari Medical | $48.93 | $66.11 | 35.11% | Buy |
SILK | Silk Road Medical | $27.49 | $30.58 | 11.24% | Buy |
SILK Forecast FAQ
Is Silk Road Medical a good buy?
Yes, according to 7 Wall Street analysts, Silk Road Medical (SILK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 57.14% of SILK's total ratings.
What is SILK's price target?
Silk Road Medical (SILK) average price target is $30.58 with a range of $20 to $46, implying a 11.24% from its last price of $27.49. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Silk Road Medical stock go up soon?
According to Wall Street analysts' prediction for SILK stock, the company can go up by 11.24% (from the last price of $27.49 to the average price target of $30.58), up by 67.33% based on the highest stock price target, and down by -27.25% based on the lowest stock price target.
Can Silk Road Medical stock reach $40?
SILK's highest twelve months analyst stock price target of $46 supports the claim that Silk Road Medical can reach $40 in the near future.
What are Silk Road Medical's analysts' financial forecasts?
Silk Road Medical's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $194.07M (high $194.95M, low $192.93M), average EBITDA is $-78.616M (high $-75.016M, low $-82.102M), average net income is $-60.637M (high $-55.611M, low $-65.664M), average SG&A $165.1M (high $171.38M, low $158.57M), and average EPS is $-1.511 (high $-1.468, low $-1.553). SILK's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $221.74M (high $221.74M, low $221.74M), average EBITDA is $-93.55M (high $-93.55M, low $-93.55M), average net income is $-52.201M (high $-52.201M, low $-52.201M), average SG&A $204.42M (high $204.42M, low $204.42M), and average EPS is $-1.317 (high $-1.317, low $-1.317).
Did the SILK's actual financial results beat the analysts' financial forecasts?
Based on Silk Road Medical's last annual report (Dec 2022), the company's revenue was $138.64M, beating the average analysts forecast of $128.88M by 7.57%. Apple's EBITDA was $-49.667M, missing the average prediction of $-52.433M by -5.28%. The company's net income was $-58.016M, missing the average estimation of $-62.979M by -7.88%. Apple's SG&A was $116.32M, beating the average forecast of $107.32M by 8.38%. Lastly, the company's EPS was $-1.62, missing the average prediction of $-1.649 by -1.73%. In terms of the last quarterly report (Sep 2023), Silk Road Medical's revenue was $44.44M, missing the average analysts' forecast of $44.53M by -0.21%. The company's EBITDA was $-13.671M, missing the average prediction of $-18.786M by -27.23%. Silk Road Medical's net income was $-12.788M, missing the average estimation of $-13.968M by -8.45%. The company's SG&A was $36.01M, missing the average forecast of $41.05M by -12.28%. Lastly, the company's EPS was $-0.33, missing the average prediction of $-0.353 by -6.39%